Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 25 hits in this display
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+3nMAssay Description:Activity was measured using electrophoretic mobility shift assays with full length human recombinant HDAC proteins and fluorescently labeled peptide ...More data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: 5.60E+3nMAssay Description:Inhibition of full length recombinant human HDAC8 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC4 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC3 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC1 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC9 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC7 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC5 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC2 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC10 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
BDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
IC50: >1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair